Cymevene - Prevention and treatment of life- or sight-threatening cytomegalovirus (CMV) disease in immunocompromised individuals.
Treatment of life-threatening or sight-threatening CMV infections in immunocompromised individuals. These states include acquired immunodeficiency syndrome (AIDS), iatrogenic immunosuppression associated with organ transplantation or chemotherapy for neoplasia. Cymevene may also be used for the prevention of CMV disease, specifically in those patients receiving immunosuppressive therapy secondary to organ transplantation.
Prevention and treatment of life- or sight-threatening cytomegalovirus (CMV) disease in immunocompromized individuals and for the prevention of CMV disease in transplant recipients.
Indications: cytomegalovirus infections
Cytomegaloviral infections, Prophylaxis of cytomegaloviral infections in immunocompromised patients, Cytomegaloviral retinitis
Gabapentin (brand name Neurontin) is a GABA analogue. It was originally developed for the treatment of epilepsy, and currently, gabapentin is widely used to relieve pain, especially neuropathic pain.
Cymevene is an antiviral medication used to treat or prevent cytomegalovirus (CMV) infections. It was first synthesized by Julien Verheyden and John Martin at Syntex Research in California in 1980.Ganciclovir sodium is marketed under the trade names Cytovene and Cymevene (Roche). Cymevene for ocular use is marketed under the trade name Vitrasert (Bausch & Lomb). A prodrug form with improved oral bioavailability (valganciclovir) has also been developed.
Indications: Herpes viruses including H.
simplex, H-zoster, E-B virus and cytomegalovirus (CMV).
It is more active against CMV.
Now a days mainly used against CMV infection.